OnabotulinumtoxinA reduces urinary incontinence and urgency and improves quality of life in patients with overactive bladder regardless of incontinence severity at baseline

被引：0
|
作者：
Drake, M. [1 ]
Ginsberg, D. [1 ]
Gruenenfelder, J. [1 ]
Moore, C. [1 ]
Kaufmann, A. [1 ]
James, C. [1 ]
Magyar, A. [1 ]
Herschorn, S. [1 ]
机构：
[1] Southmead Hosp, Bristol Urol Inst, Bristol, Avon, England
来源：
BJU INTERNATIONAL | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P61
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES URINARY INCONTINENCE AND QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS REGARDLESS OF INCONTINENCE SEVERITY AT BASELINE
    Ginsberg, D.
    Gruenenfelder, J.
    Moore, C.
    Kaufmann, A.
    Drake, M.
    Joshi, M.
    Magyar, A.
    Herschorn, S.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S109 - S110
  • [2] ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Khullar, V.
    Sand, P.
    Parsons, M.
    Zhou, J.
    Globe, D.
    Nardo, C.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S13 - S14
  • [3] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE
    Sand, P. K.
    Khalaf, K. M.
    Yan, X.
    Globe, D.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192
  • [4] TREATMENT WITH ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES EPISODES OF URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME
    Sand, Peter
    Parsons, Matthew
    Zhou, Jihao
    Globe, Denise
    Nardo, Christopher
    Khullar, Vik
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 209 - 209
  • [5] OnabotulinumtoxinA for Overactive Bladder and Urinary Incontinence
    Chancellor, Michael B.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (02): : S224 - S236
  • [6] Efficacy of fesoterodine on overactive bladder symptoms in subjects with different baseline severity of urgency urinary incontinence
    Cardozo, L.
    Sand, P.
    Khullar, V
    Wang, J.
    Guan, Z.
    Wein, A.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S38 - S39
  • [7] Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?
    Cardozo, Linda
    Khullar, Vik
    Wang, Joseph T.
    Guan, Zhonghong
    Sand, Peter K.
    [J]. BJU INTERNATIONAL, 2010, 106 (06) : 816 - 821
  • [8] Fesoterodine Versus Tolterodine for Improving Urgency Urinary Incontinence and Patient-Reported Outcomes in Women with Overactive Bladder: Effect of Baseline Urgency Urinary Incontinence Severity
    Lee, Richard
    Zou, Kelly H.
    Wang, Joseph T.
    Bavendam, Tamara
    Trocio, Jeffrey
    [J]. JOURNAL OF WOMENS HEALTH, 2011, 20 (03) : 491 - 491
  • [9] Fesoterodine vs Tolterodine for Overactive Bladder in Older Subjects: Effect of Baseline Urgency Urinary Incontinence Severity
    Lee, R.
    Zou, K. H.
    Bavendam, T.
    Trocio, J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S124 - S125
  • [10] Impact of urinary incontinence and overactive bladder on quality of life
    Chiaffarino, F
    Parazzini, F
    Lavezzari, M
    Giambanco, V
    [J]. EUROPEAN UROLOGY, 2003, 43 (05) : 535 - 538
12345